ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional Results available

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

ClinicalTrials.gov ID: NCT03706365

Public ClinicalTrials.gov record NCT03706365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 9:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Study identification

NCT ID
NCT03706365
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
393 participants

Conditions and interventions

Interventions

  • Abemaciclib Drug
  • Abiraterone acetate Drug
  • Placebo Drug
  • Prednisone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2018
Primary completion
Jan 1, 2024
Completion
May 31, 2026
Last update posted
Apr 23, 2026

2018 – 2026

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center Phoenix Arizona 85004
Mayo Clinic in Arizona - Phoenix Phoenix Arizona 85054
The University of Arizona Cancer Center - North Campus Tucson Arizona 85719
St. Bernards Medical Center Jonesboro Arkansas 72401
CBCC Global Research, Inc. Bakersfield California 93309
Providence St. Jude Medical Center Fullerton California 92835
Moores Cancer Center La Jolla California 92093
TRIO-US (Translational Research in Oncology-US) Los Angeles California 90024
UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles California 90095
Pacific Cancer Care Monterey California 93940
Sansum Clinic_Kendle Santa Barbara California 93105
Rocky Mountain Cancer Center Lone Tree Colorado 80124
Millennium Oncology - Hollywood Hollywood Florida 33024
Northside Hospital Atlanta Georgia 30342
Fort Wayne Medical Oncology And Hematology at Parkview Comprehensive Cancer Center Fort Wayne Indiana 46804
Massachusetts General Hospital Boston Massachusetts 02114
M Health Fairview University of Minnesota Medical Center - East Bank Minneapolis Minnesota 55455
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89119
New York Oncology Hematology (NYOH) - Clifton Park Cancer Center Albany New York 12206
Associated Medical Professionals - Urology Syracuse New York 13210
Research Medical Center Nashville Tennessee 37203
Baylor Scott & White Medical Center - Temple Temple Texas 76508
New York Oncology Hematology (NYOH) - Clifton Park Cancer Center The Woodlands Texas 77380
Northwest Cancer Specialists PC The Woodlands Texas 77380
Sansum Clinic_Kendle The Woodlands Texas 77380
Texas Oncology - Longview Cancer Center The Woodlands Texas 77380
Texas Oncology Cancer Care and Research Center The Woodlands Texas 77380
Texas Oncology Fort Worth The Woodlands Texas 77380
Texas Oncology-Memorial City The Woodlands Texas 77380
US Oncology The Woodlands Texas 77380
USO-Cancer Care Center of Brevard, Inc. The Woodlands Texas 77380
Huntsman Cancer Institute Salt Lake City Utah 84112
The University of Vermont Medical Center Inc. Burlington Vermont 05405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03706365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03706365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →